NASDAQ
Hansa Biopharma AB (publ) (HNSBF) has a interest coverage ratio of -4.40x as of Friday, May 29, 2026. This represents a 97.83% increase compared to its 12-month average of -203.13x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.